Weisi Medical Announces Share Repurchase Progress as of November 30, 2022

VISHEE Medical announced on December 4 that, as of November 30, 2022, the company had cumulatively repurchased 323,400 shares through centralized bidding on the Shanghai Stock Exchange, accounting for 0.4714% of the company's total share capital. The highest price for the repurchase was RMB 50.93 per share, and the lowest price was RMB 42.78 per share. The total amount of funds paid was approximately RMB 14.8578 million (excluding stamp duty, transaction commissions, and other transaction costs).